Aridis Provides Corporate Update
December 20, 2024 08:00 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent...
Montauk Metals Provides Corporate Update
December 05, 2024 18:57 ET
|
Montauk Metals Inc.
TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Montauk Metals Inc. (TSX-V: MTK) (the “Company” or “Montauk”) announces that the Company received USD$504,000 from the Republic of Colombia as a costs...
Clear Blue Technologies Announces Q3 2024 Financial Results & Provides Corporate Update
November 28, 2024 19:18 ET
|
Clear Blue Technologies International Inc.
TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) (FRANKFURT: OYA), the Smart Off-Grid™ Company, announces its financial results for the third...
Clear Blue Technologies International to provide Corporate Update and Report Third Quarter Fiscal 2024 Financial Results and Host Conference Call on Friday, November 29, 2024
November 22, 2024 14:14 ET
|
Clear Blue Technologies International Inc.
TORONTO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announced that it will provide a corporate update and also...
Abaxx Provides Q3 2024 Corporate Update
November 15, 2024 07:30 ET
|
Abaxx Technologies Inc.
TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE CA:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority...
Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 06, 2024 07:30 ET
|
Arbutus Biopharma Corporation
Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD - The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the Phase...
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 05, 2024 07:00 ET
|
AC Immune SA
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update ACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease (PD) on track to report interim safety and...
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
November 01, 2024 16:50 ET
|
NurExone Biologic Inc
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
Cavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SA
October 28, 2024 09:00 ET
|
Cavitation Technologies, Inc
CHATSWORTH, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB: CVAT), a leading ESG company designing and manufacturing innovative flow-through...
Bocana Resources Corp. Provides a Corporate Update
October 17, 2024 07:30 ET
|
Bocana Resources Corp.
CALGARY, Alberta, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ("Bocana" or “Company”) announces it has received an extension from the TSX Venture Exchange...